Bristol Myers Squibb Co (BMY): insider trading, Congress trades & who owns it

Insider signal
35/100
Insider selling · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$2.3M
3 sellers · 12 months
Funds holding
2,513
13F · Q2 2026
Congress trades
19
10 members · 2 years

Bristol Myers Squibb Co corporate insiders have only been selling lately: three insiders trimmed about $2.3 million of stock over 12 months, with no open-market purchases.

Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.

2,513 investment managers listed BMY in their latest 13F filings (Q2 2026); funds were split between buying and selling. Members of Congress reported 19 trades in BMY over the past two years (ten members). Looking at the quarterly pattern: 2 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters.

Want the full picture on BMY? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full BMY report — free account

Latest insider trades in BMY

FiledInsiderRoleTypeSharesPriceValueSource
Sep 10, 2026Massacesi CristianExecutive OfficerSell6,249$64.57$403KSEC
Aug 26, 2026Holzer Phil MExecutive OfficerSell500$67.50$34KSEC
Apr 2, 2026Elkins David VCFOSell25,519$61.60$1.6MSEC
Apr 2, 2026Elkins David VCFOSell4,481$62.05$278KSEC
Sep 3, 2025Elkins David VCFOSell56,000$47.33$2.7MSEC
Aug 5, 2025Short Bartie WendyExecutive OfficerSell378$44.23$17KSEC
May 13, 2025Hickey BenjaminPresidentSell97$38.01$4KSEC
Apr 29, 2025Hirawat SamitExecutive OfficerBuy4,250$47.58$202KSEC
Feb 21, 2025BOERNER CHRISTOPHER S.CEOBuy2,000$55.05$110KSEC
Feb 19, 2025Hirawat SamitExecutive OfficerBuy1,823$54.84$100KSEC
Nov 5, 2024Holzer Phil MExecutive OfficerSell700$55.62$39KSEC
Nov 5, 2024Hirawat SamitExecutive OfficerBuy1,830$54.68$100KSEC
Dec 7, 2023BOERNER CHRISTOPHER S.CEOBuy2,000$49.78$100KSEC
Nov 30, 2023BOERNER CHRISTOPHER S.CEOBuy3,071$48.86$150KSEC
Nov 21, 2023Samuels Theodore R. IIDirectorBuy8,500$49.81$423KSEC

Congress trades in BMY Free

FiledMemberTypeAmountSource
Aug 5, 2026Tommy Tuberville RSale$1,001 - $15,000Official filing
Jul 21, 2026Alan Armstrong RPurchase$1,001 - $15,000Official filing
Jun 11, 2026Mike Kelly RSale$15,001 - $50,000Official filing
Jan 15, 2026Julie Johnson DSale$1,001 - $15,000Official filing
Jan 13, 2026Julia Letlow RSale$1,001 - $15,000Official filing
Jan 13, 2026Julia Letlow RPurchase$1,001 - $15,000Official filing
Jan 12, 2026Gilbert Ray Cisneros, Jr. DPurchase$1,001 - $15,000Official filing
Dec 15, 2025Gilbert Ray Cisneros, Jr. DPurchase$1,001 - $15,000Official filing

Questions about BMY

Are insiders buying or selling BMY stock?

In the last 12 months Bristol Myers Squibb Co insiders made open-market purchases worth about $0 and sales worth about $2.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in BMY?

The most recent open-market insider trade in BMY was filed on 2026-09-10.

How many institutions own BMY?

2,513 investment managers reported holding BMY in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded BMY?

Yes. Members of Congress reported 19 trades in BMY over the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).